Malesci Istituto Farmacobiologico

Istituto Farmacobiologico Malesci is a historic Italian pharmaceutical company headquartered in Florence, founded in 1921. In 1992, the company was acquired by the Menarini Group, Italy's leading pharmaceutical multinational, and it currently operates as a specialized subsidiary within the group. Malesci focuses on the commercialization of high-quality therapeutic products, with a primary emphasis on cardiovascular, metabolic, and respiratory diseases. Its portfolio includes well-established treatments for conditions such as hypertension, type 2 diabetes, and dyslipidemia. The company plays a significant role in the Italian healthcare system by providing essential medications and maintaining strong relationships with medical professionals. Through its integration with Menarini, Malesci leverages extensive R&D and manufacturing capabilities to support its product line.